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Regenerative medicineSeveral studies have reported the beneﬁcial effects of mesenchymal stem cells (MSCs) in tissue repair and regen-
eration. New sources of stem cells in adult organisms are continuously emerging; dental tissues have been iden-
tiﬁed as a source of postnatal MSCs. Dental bud is the immature precursor of the tooth, is easy to access and we
show in this study that it can yield a high number of cells with ≥95% expression of mesenchymal stemness
makers and osteogenic capacity. Thus, these cells can be deﬁned as Dental Bud Stem Cells (DBSCs) representing
a promising source for bone regeneration of stomatognathic as well as other systems. Cell interactions with the
extracellular matrix (ECM) and neighboring cells are critical for tissue morphogenesis and architecture; such in-
teractions are mediated by integrins and cadherins respectively. We characterized DBSCs for the expression of
these adhesion receptors and examined their pattern during osteogenic differentiation. Our data indicate that
N-cadherin and cadherin-11 were expressed in undifferentiated DBSCs and their expression underwent changes
during the osteogenic process (decreasing and increasing respectively), while expression of E-cadherin and P-
cadherin was very low in DBSCs and did not change during the differentiation steps. Such expression pattern
reﬂected the mesenchymal origin of DBSCs and conﬁrmed their osteoblast-like features. On the other hand, os-
teogenic stimulation induced the upregulation of single subunits,αV,β3,α5, and the formation of integrin recep-
torsα5β1 andαVβ3. DBSCs differentiation toward osteoblastic lineage was enhancedwhen cells were grown on
ﬁbronectin (FN), vitronectin (VTN), and osteopontin (OPN), ECM glycoproteins which contain an integrin-bind-
ing sequence, the RGD motif. In addition we established that integrin αVβ3 plays a crucial role during the com-
mitment of MSCs to osteoblast lineage, whereas integrinα5β1 seems to be dispensable. These data suggest that
functionalization of biomaterials with such ECM proteins would improve bone reconstruction therapies starting
from dental stem cells.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Numerous studies have reported beneﬁcial effects of multipotent
MSCs in tissue repair and regeneration (Marx and Harrell, 2014; Otte
et al., 2013; Yamaguchi, 2014). These cells can be isolated from manys, dental bud stem cells; ECM,
N, osteopontin; BMMSCs, bone
ells; DFSCs, dental follicle stem
.
xperimental Medicine, Medical
Italy.
nedetto).
. This is an open access article underdifferent adult tissues, are self-renewable and can differentiate into all
cell lineages that form mesenchymal and connective tissues
(Yamaguchi, 2014; Barthes et al., 2014; Paschos and Brown, 2014).
The most well characterized source for MSCs is still the bone
marrow, however in the past decade, populations of stem cells have
been isolated from different dental tissues (Gronthos et al., 2000;
Miura et al., 2003). A population of adult stem cells isolated from dental
pulp (DP) tissues and designed as dental pulp stem cells (DPSCs), has
been identiﬁed as a promising source of MSCs for tissue engineering
(Gronthos et al., 2000; Daltoe et al., 2014; Mori et al., 2011; Mori et al.,
2010; Spath et al., 2010; d'Aquino et al., 2009; Mangano et al., 2010;
Galli et al., 2011; Mangano et al., 2011).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Dental Bud (DB). DF is the loose connective tissue sac that surrounds
the dental bud, which is the unerupted deciduous tooth. These tissues
are more undifferentiated than mature Dental Pulp, thus dental bud is
amore productive tissue ofMSCs thanmature DP andwould have alter-
native applications in bone and periodontal tissue engineering (Huang
et al., 2009; Shi et al., 2001).
DBSCs give rise to all the tissues present in the mature tooth:
enamel, dentin, pulp, cement, and periodontal ligament. We show
in the present paper that the central part of the bud, corresponding
to the dental papilla, contains the MSCs which can differentiate
into osteoblast-like cells. To obtain these postnatal stem cells, the ex-
traction of a tooth before its eruption is required; however, the early
removal (age 7–12) of the dental bud of third molars yields excellent
stem cells. Furthermore, patients selected for the extraction are often
subjects that will undergo dental crowding which is worsened by
wisdom teeth eruption, thus they will not lose a functional tooth.
Since the stemness and osteogenic commitment of DFSCs has been
previously established (Mori et al., 2012), these cells represent an
excellent source for tissue engineering therapy and we can speculate
on their possible use for bone regeneration of stomatognathic and
other systems. In order to obtain an efﬁcacious reconstruction of
bone tissue, stem cells must grow and differentiate in osteogenic
conditions on biomaterial scaffolds to be subsequently implanted in
vivo. However the new bone formation or the osteointegration
with the resident bone tissue sometimes result to be ineffective
due to a failed recruitment and adhesion of stem cells on the scaffold.
To achieve the correct tissue architecture during morphogenesis,
cells must interact each other and with ECM. These interactions are
mediated by two classes of adhesion receptors, respectively
cadherins and integrins (Weber et al., 2011; Chen and Gumbiner,
2006; Berrier and Yamada, 2007). Cadherins are single chain trans-
membrane glycoproteins that mediate cell–cell adhesion and inter-
fere with intracellular signaling, in particular the Wnt/b-catenin
pathway (Nelson and Nusse, 2004; MacDonald et al., 2009). They
control proliferation, differentiation and survival of MSCs, which ex-
press low levels of multiple cadherins and their pattern changes as
stem cells are committed to a differentiated cell lineage. Several in
vivo and in vitro studies have established a main role of cadherins,
in particular N-cadherin and cadherin-11, in osteoblastogenesis
and bone formation either by controlling cell-cell adhesion or
interacting with Wnt intracellular signaling (Schambony et al.,
2004; Bienz, 2005; Brembeck et al., 2006). Expanding the knowledge
on cadherin expression inMSCs of dental origin would be fundamen-
tal to promote the possible use of these cells in bone reconstruction
therapies. Thus, as already demonstrated for DFSCs (Mori et al.,
2012), the stemness and osteogenic commitment of DBSCs was con-
ﬁrmed. Further, these cells were characterized for the expression of
cadherins and their pattern examined during osteogenic differentia-
tion. To achieve the goal of bone regeneration and osteointegration,
it would be also important to examine cell–matrix interaction medi-
ated by integrins. These are a family of cell surface receptors that pri-
marily mediate adhesion of cells to the ECM proteins. Integrins are
heterodimeric transmembrane proteins, consisting of associated α
and β subunits, with a large extracellular domain and a short cyto-
plasmic tail. Differently combinedα and β subunits result in a variety
of integrin heterodimers that can bind a speciﬁc repertoire of ECM
proteins. Among others are ﬁbronectin, laminin, collagens, tenascin,
vitronectin, osteopontin, bone sialoprotein, and dentinmatrix protein-1
(Docheva et al., 2007). Besides, integrins transmit crucial signals inside
the cells. Adhesion of MSCs to ECM is still poorly characterized, as well
as protein matrix role in regulating osteogenic differentiation. Thus we
characterized our cell model of DBSCs for the expression of four integrin
subunits and receptor heterodimers and then analyzed the effect of
DBSC adhesion on three ECM glycoproteins containing the integrin-
binding sequence RGD, namely FN, VTN, and OPN.2. Results
2.1. Immunophenotype of DBSCs
DBSCs from 20 donors were tested for the criteria to be called MSCs
(Dominici et al., 2006), as was done for DFSCs (Mori et al., 2012), in
order to ensure that these cells had actually stem andmesenchymal fea-
ture. Flow cytometric analysis of research accepted MSC surface
markers was performed and all populations exhibited ≥95% expression
of CD73, CD90, and CD105 while were negative for CD45, a common
leukocyte antigen. DBSC samples from three donors were selected to
perform the experiments, since they showed higher and similar per-
centage values of stemness marker expression. Fig. 1 upper panel,
shows ﬂow cytometry histograms from one representative DBSC
culture.
2.2. Cadherin expression proﬁle in DBSCs reﬂected their mesenchymal
origin
Expression of “classical” cadherins was investigated in undifferenti-
ated DBSCs and during their osteogenic differentiation. The cells were
kept in favoring conditions for MSC maintenance and were character-
ized for cadherin expression. Subcellular localization showed a high ex-
pression of N-cadherin, as well as for cadherin-11 (Fig. 1 A–B). E-
cadherin was expressed to a lesser extent and P-cadherin was poorly
expressed (Fig. 1 C–D). Notably, only N-cadherin was markedly local-
ized at the cell–cell contact, perhaps contributing to maintain the stem
cells niche in the dental bud.
Thus cadherin expression proﬁle was evaluated during osteogenic
differentiation. As already demonstrated for DFSCs, (Mori et al., 2012)
DBSCs cultured under osteogenic conditions differentiated into osteo-
blast-like cells producing mineralized matrix nodules and expressed
the typical osteoblastic markers Runx-2, alkaline phosphatase (ALP),
and Collagen I (Coll I) (data not shown). Cadherin expression proﬁle
was analyzed by Western blotting during the different steps of osteo-
genic differentiation. As shown in Fig. 1 panel E, N-cadherin was
expressed in undifferentiated DBSCs, thus conﬁrming the subcellular
observation; its expression remained constant after 7 days of osteogenic
differentiation, but a slight decrease initiated after 14 days keeping a
low expression of differentiation at 21 and 28 days. Similarly, cadherin-
11 was expressed in undifferentiated DBSCs and its expression did not
change after 7 days of differentiation, however after 2 weeks
cadherin-11 strongly increased and remained highly expressed also at
the later stages. Thus, while N-cadherin and cadherin-11 were present
in undifferentiated DBSCs and their expression underwent changes dur-
ing the osteogenic process, expression of E-cadherin and P-cadherin
was low in DBSCs and did not change during the differentiation steps.
Such expression proﬁle of cadherins in DBSCs, and more precisely the
changes undergoing cadherin-11 and N-cadherin (increasing and de-
creasing respectively), conﬁrmed that these stem cells can acquire an
osteoblastic phenotype under appropriate osteogenic conditions. The
subcellular localization of cadherins was observed only during the
early phases of osteogenic differentiation (3–7 days), since these cells
usually reach the conﬂuence in few days and grow in multilayers, thus
preventing their microscopic observation. E-cadherin and P-cadherin
were poorly expressed and homogenously distributed in DBSCs and
their localization did not change after 3–7 days of osteogenic trigger
(data not shown) as their expression until 28 days of differentiation
(Fig. 1 panel E). Conversely N-cadherin and cadherin-11 changed their
localization in response to osteogenic stimulation. In Fig. 1 (bis) F on
time zero (T0) N-cadherin was localized at the cell–cell adhesion sites,
being probably involved in the formation of adherens junction com-
plexes as revealed by the “red bridges”mergingwith actin cytoskeleton
marked by Phalloidin and resulting in an intense yellow staining. After
3 days N-cadherin remained localized in the adherens junction com-
plex, while after 7 days N-cadherin lost the characteristic bridge-like
Fig. 1. Upper panel: immunophenotype of DFSCs. The expression of the indicated mesenchymal stem cell markers on DBSCs was analyzed using ﬂow cytometry. Results from one repre-
sentative DBSCs culture are shown. The black histograms signify staining with isotype controls, and the white histograms represent staining with the speciﬁed surface marker antibody.
Lower panel: Cadherin expression proﬁle in DBSCs. Midsection confocal microscopy images of DBSCs cultured in basal conditions, counterstained for different type of Cadherins (red) and
Phalloindin (green). Subcellular localization shows high expression of N-Cadherin (markedly localized at the cell–cell contact) and Cadherin-11 (A–B). E-Cadherin and P-Cadherin are
expressed to a lesser extent (C–D). Results are depicted for one donor but are representative of three different donors. (E) Immunoblots showing the cadherin expression proﬁle during
the osteogenic differentiation process (0–28 days). Data are presented asmean±SEMof 3 independent donors *P b 0.01 and #P b 0.05 compared to T0. Student's t-testwas used for single
comparison. Fig. 1 (bis): Confocal images show that N-Cadherin and Cadherin-11 change their localization in response to osteogenic stimulation (F–K). On time zero (F) and after 3 days
(G), N-Cadherin is localized at the cell–cell adhesion sites forming “red bridges”, while after 7 days N-Cadherin loses the characteristic bridge-like appearance (H). Cadherin-11 accumu-
lates and localizes at adherens junction sites after 3–7 days of differentiation (J–K).
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Fig. 1 (continued).
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changing its expression. On the contrary cadherin-11 seemed to have
an opposite trend. Indeed on T0, DBSCs expressed Cadherin-11, which
was not localized at the cell–cell adhesion sites, but homogenously dis-
tributed in multiple sites. After 7 days of osteogenic differentiation,
cadherin-11 accumulated at the cell periphery and localized at
adherens junction sites acquiring the bridge-like trend observed for
N-cadherin in less differentiated cells.
2.3.αV andβ3 integrin subunits increase during DBSCs osteogenic differen-
tiation and form the functional integrin
Integrins trigger tissues morphogenesis, thus we investigated the
subunits expressed in mesenchymal tissues (Shin et al., 2004; Takada
et al., 2007; Schwab et al., 2013).
Again, due to the rapid propensity of the cells to form a multilayer,
the presence of single integrin subunitsαV andβ3was analyzed by con-
focal microscopy in DBSCs undifferentiated and after 7 days of osteo-
genic differentiation. As shown in Fig. 2 A–C both subunits were
localized on the surface of undifferentiated cells, distributed in multiple
sites and after 7 days of differentiation, each subunit seemed to reorga-
nize and localize at the focal adhesion sites (Fig. 2 B–D). The expression
proﬁle ofαV andβ3was analyzed byWestern blottingduring 28days of
osteogenic differentiation (Fig. 2, panel E) conﬁrming that both subunits
were expressed at T0, increased after 7 days and progressively raised.
Since integrin receptors are heterodimeric molecules, and alpha sub-
units form complexes with various beta subunits, we veriﬁed if αV
and β3 were associated in DBSCs and formed the integrin complex.
DBSCs co-stained for αV (red) and β3 (green) (Fig. 2 F–G), showed
some dots of colocalization (yellow staining) in osteogenic condition
(7 days) (Fig. 2 G), suggesting that the subunits could be associated.
To assess whether the subunits αV and β3 were associated to form
the integrin receptor,whole cell lysates of DBSCs in basal and osteogenic
condition for 7–14–21–28 days were immunoprecipitated with LM609
antibody (which recognizes only the complex) and western blotted
with αV and β3 antibodies (Fig. 2 H). This experiment failed to reveal
the association of αV and β3 in undifferentiated DBSCs, while showed
that the presence of the receptor dimer was strictly time dependingduring the differentiation process, reaching the higher expression after
21 days in DBSCs that turned in osteoblast-like cells. The subcellular distri-
bution of integrin αVβ3, observed by confocal microscopy, revealed a
scarce presence of the receptor in undifferentiated DBSCs (possibly not de-
tected by the biochemical assay), however its localization appeared strong-
ly augmented on the focal contacts in differentiated cells. (Fig. 2 I–J; K–L).
2.4. Increased expression ofα5 integrin subunits in DBSCs osteogenic differ-
entiation and association with β1 subunit
The expression of α5 and β1 subunits was detected by confocal mi-
croscopy in undifferentiated DBSCs showing that bothwere present and
homogenously localized on the cell surface (Fig. 3 A–C). After 7 days in
osteogenic conditions, expression of α5 seemed to increase and accu-
mulate in large peripheral clusters apparently localized on the base of
the cell. The same trend was observed for β1 suggesting that following
the osteogenic trigger the subunits were recruited to form the integrin
receptor (Fig. 3 B–D). Furthermore, the expression trend of both sub-
units was analyzed by Western blotting during 28 days of osteogenic
differentiation.α5was upregulatedmainly at 7–14–28 days of differen-
tiation (Fig. 3 panel E), while β1 did not exhibit signiﬁcant expression
changes. As shown in Fig. 3 F–G, where α5 was stained in green and
β1 in red, the two subunits appeared mainly separated in undifferenti-
ated cells, with only fewmerged yellow dots, whereas they co-localized
in differentiated cells and accumulated on the focal contacts. Immuno-
precipitation experiments conﬁrmed thatα5 andβ1were physically as-
sociated essentially in differentiated cells.
2.5. Interaction of integrins with correspondent extracellular matrix pro-
teins enhances osteogenic differentiation and mineralization of DBSCs
We found that DBSCs expressed integrin subunitsαV,β3,α5, andβ1
and that osteogenic trigger enhanced the expression of αV, β3, and α5.
Additionally, the osteogenic differentiation induced the association of
single subunits to form the integrin heterodimers αVβ3 and α5β1,
that localized at the focal adhesions. Integrin binding to ECM proteins
affects intracellular signaling cascades involved in cell adhesion andmi-
gration, aswell as in stem cell commitment and differentiation. Thuswe
622 A. Di Benedetto et al. / Stem Cell Research 15 (2015) 618–628investigated DBSCs osteogenic differentiation in the presence of three
different ECM proteins, FN (which binds α5β1 and to a lesser extent
αVβ3), VTN (which binds only αVβ3), and OPN (which binds αVβ3and to a lesser extentα5β1). The cells were seeded on the three protein
coatings and on poly-L-lysine (PLL) as control (CTR), and cultured in
osteogenic conditions. Western blot analysis was performed to
623A. Di Benedetto et al. / Stem Cell Research 15 (2015) 618–628investigate the expression of two earlymarkers of osteogenic differenti-
ation, Runx-2 and Collagen I (Col I), that were found to increase during
osteogenic differentiation of DFSCs (Mori et al., 2012). Moreover, using
histochemical assays, we evaluated the expression of the osteoblast
marker ALP after 7 days and the mineralization capacity with ARS
after 21 days.
The differentiation pattern of DBSCs on all 3 surfaces was enhanced
in comparison to the control (Fig. 4). Indeed we detected higher abun-
dance of Runx2 and Col1 protein in DBSCs differentiated for 7 days on
FN, VTN, and OPN, relative to CTR conditions (Fig. 4 A). In particular
cells grown on FN showed a 18% and 30% increase of Runx2 and Col1 re-
spectively, while the increase of bothmarkers wasmore accentuated on
VTN and OPN (VTN: 45% for Runx2, 73% for Col1; OPN: 46% for Runx2,
52% for Col1). This suggests that integrin interaction with ECM proteins
promoted intracellular responses essential for the commitment of
DBSCs to osteogenic phenotype. Therefore, we applied a histochemical
assay to assess the ability to differentiate in osteoblast-like cells evaluat-
ing ALP expression and found that after 7 day interaction with the all
three ECM proteins highly increased ALP staining, as revealed by pixel
quantiﬁcation. Accordingly, mineral matrix nodule deposition capacity
assayed after 21 days by ARS staining, was signiﬁcantly higher in cells
cultured on all three coating surfaces compared to control coating
(Fig. 4. B). Differentiation on FN was apparently less accentuated as re-
vealed especially by Runx2 and Col1 expression and mineralization, al-
though the differences observed among the different ECM proteins
were not signiﬁcant. This might be due to the observation that both
integrins, α5β1 and αVβ3 had a similar expression trend during osteo-
genic differentiation of DBSCs and interaction with their ECM partners
activated signaling cascades that gave positive cues to osteogenic differ-
entiation. To establish if such interactions were essential for the com-
mitment of DBSCs to osteogenic phenotype, we performed the same
culture conditions in the presence of neutralizing antibodies directed
against integrins α5β1 and αVβ3. More precisely the antibody against
α5β1 was added to the FN coating cultures, while the antibody against
αVβ3 to VTN and OPN coating cultures. We showed that the treatment
with anti-αVβ3 completely reversed the increase of ALP and ARS stain-
ing in cultures of DBSCs differentiated on VTN and OPN, while, the inhi-
bition of interaction betweenα5β1 and FN failed to reach similar results
(Fig. 4 C). This ﬁnding demonstrated that enhanced differentiation of
DBSCs to osteoblast phenotype achieved by culturing these cells on
VTN and OPN is strictly dependent by the adhesion via αVβ3. By con-
trast, the increased differentiation on FN coating dispensed from inter-
action with integrin α5β1.
3. Discussion
Dental tissues represent an alternative and promising source of post-
natal MSCs for tissue engineering (Gronthos et al., 2000; Ballini et al.,
2007; Mori et al., 2013; Di Benedetto et al., 2014). Indeed, despite
other sources of MSCs in the adult body (bone marrow, adipose tissue,
skin, brain, liver, etc.), dental tissues are formed at a later stage and
therefore with a high amount of stem cells, due to late completion of
odontogenesis process and tooth eruption. Furthermore DPSCs and
DBSCs can be obtained from the wisdom tooth (mature and at the
stage of germ respectively) not essential for human masticatory func-
tion and frequently extracted for orthodontic reasons or dysodontiasis.
In addition, the tooth extraction, especially by piezo-surgery technique,Fig. 2. Expression ofαV andβ3 subunits and formation of the functional Integrin in DBSCs;mids
β3 (red) in basal and differentiated conditions, cytoskeleton was counterstained with green Ph
entiated cells. After 7 days of differentiation, each subunit seems to localize on the periphery of
pression ofαV andβ3 during the osteogenic differentiation process (0–28 days) ofDBSCs. Each g
T0. Student's t-test was used for single comparison. (F–G) DBSCs co-stained forαV (red), β3 (g
(G). (H) Protein were immunoprecipitated with LM609 antibody (which recognizes only theα
antibodywas also used to detect by confocalmicroscopy the subcellular distribution of integrinα
cells show a very mild presence of the receptor (I-L), perhaps not detected by the immunopre
αVβ3 in correspondence of the focal contacts (J–L). Results are depicted for one donor but areis less invasive compared to bone marrow or other tissue biopsy. The
challenge of new bone formation and graft integration is strictly depen-
dent on recruitment and adhesion of stem cells on the scaffolds, to ob-
tain a successful cell commitment and differentiation. The cell
adhesion molecules cadherins and integrins, address tissue morpho-
genesis and architecture, but also act intracellularly by modulating cru-
cial pathways of cell commitment and differentiation. A main role of
some cadherins has been established in the control of mesenchymal
cells survival, proliferation, and differentiation (Larue et al., 1996;
Wheelock and Johnson, 2003; Gumbiner, 2005) and in osteoblastogen-
esis and bone formation (Cheng et al., 1998; Ferrari et al., 2000;
Kawaguchi et al., 2001; Lemonnier et al., 2001). In this work, expression
of “classical” cadherinswas characterized in undifferentiated DBSCs and
during their osteogenic differentiation. Our data indicated that N-
cadherin and cadherin-11 were expressed in undifferentiated DBSCs
and their expression underwent changes during the osteogenic process
(decreasing and increasing respectively), while expression of E-
cadherin and P-cadherin was low in DBSCs and did not change during
the differentiation steps. Similar expression pattern was reported in
various cell lines of the mesenchymal lineage (Cheng et al., 1998; Shin
et al., 2000; Marie et al., 2014; Marie and Hay, 2013). Kawaguchi et al.,
2001 found that N-Cadwas expressed in different lines ofmesenchymal
cells, Cad-11 in preosteoblasts, preadipocytes, and in differentiated os-
teoblast while decreased in adipocyte cells, while P-Cad was only poor
expressed in calvaria OBs. More recently, Alimperti et al. (2014) report-
ed that human hair follicle derived MSCs (HF-MSCs) expressed both N-
Cadherin and Cadherin 11, that localized at the cell–cell contact sites. In
addition our data indicated different subcellular localization, with N-
cadherin forming adherens junctions in undifferentiated cells, while
cadherin-11 only in differentiated cells. The cadherin results reﬂected
the mesenchymal origin of DBSCs and conﬁrmed their osteoblast-like
features. Indeed literature data support that both N-cadherin and
cadherin-11 prompt the osteogenic commitment of precursor cells,
but to proceed in the osteogenic program and terminal differentiation
N-cadherin must be down regulated and Cadherin-11 highly expressed
in fully differentiated osteoblasts (Lai et al., 2006; Greenbaum et al.,
2012; Di Benedetto et al., 2010). Furthermore a recent review from
Alimperti (Alimperti and Andreadis, 2015) elegantly summarized the
body of evidences that N-Cad and Cad-11 are present in all mesenchy-
mal cells but their expression patternmay vary as they commit to differ-
ent lineage, or during the transition from one cellular type to another.
For example it is accepted that the epithelial to mesenchymal transition
(EMT) is characterized by augmented expression of N-Cad and Cad11
and diminished expression of E-Cad. The latter observation is also in
agreement with our ﬁnding showing a very low expression E-Cadherin
in DBSCs. This supported the issue to address a possible use of DBSCs as
bone forming cells, of stomatognathic and other systems. The effective-
ness of bone regeneration depends on cell adhesion on biomaterial scaf-
folds, and several studies suggested that cues from ECM regulated cell
adhesion and migration but also differentiation by activating speciﬁc
integrin subunits and heterodimers (Cheng et al., 2001; El-Amin et al.,
2002; Schneider et al., 2001; Hamidouche et al., 2009). Our data indicat-
ed that osteogenic trigger in DBSCs, induced the upregulation of single
subunits, αV, β3, α5, and the formation of integrin receptors α5β1
and αVβ3, localized in the adhesion sites of the cells to the underlying
ECM, well known as focal adhesions. MSCs adhere mainly via α5β1-
integrin binding to FN (Ode et al., 2010) and via αVβ3-integrin to OPNection confocal microscopy images show the expression of single integrin subunitsαV and
alloidin. A–C show that both single subunits were distributed in multiple sites in undiffer-
the cell where are the focal adhesion sites (B–D). (E) Immunoblots showing the trend ex-
raph representsmeans+ SE of 3 independent donors. *P b 0.01 and#P b 0.05 compared to
reen), show some dots of colocalization (yellow staining) in osteogenic condition (7 days)
Vβ3 complex) and blotted with antibodies for the single subunits αV and β3. (I–L) LM609
Vβ3 (red). Actin cytoskeletonwas counterstainedwith green Phalloidin. Undifferentiated
cipitation assay. Differentiated cells, showed strongly augmented localization of integrin
representative of three different donors.
Fig. 3. Expression ofα5 and β1 subunits and formation of the functional integrin in DBSCs:Midsection confocal microscopy images show the expression of single integrin subunitsαV and
β3 (red) in basal and differentiated conditions (7 days), Phalloidin is green. A–C show that both subunits were homogenously localized on the cell surface. After 7 days in osteogenic con-
ditions, expression of both subunits accumulates in large peripheral clusters (B–D). (E) Immunoblots showing the trend expression of αV and β3 during the osteogenic differentiation
process (0–28 days). Each graph represents means + SE of 3 independent donors. *P b 0.01 compared to T0. Student's t-test was used for single comparison. (F–G) DBSCs co-stained
for α5 (green) and β1 (red), show some dots of colocalization (yellow staining) in osteogenic condition (7 days) (G). (H) Immunoblots of protein immunoprecipitated with antibody
JBS5 (which recognizes only theα5β1 complex) and blottedwithα5 andβ1 antibodies, show that subunits are physically associated essentially in differentiated cells. Results are depicted
for one donor but are representative of the three different donors.
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cultured under osteogenic conditions, their commitment to the osteo-
blastic lineage and their ability to form a mineralized matrix increased
in the presence of FN and OPN (Schwab et al., 2013). We cultured
DBSCs on FN, VTN, and OPN coated surfaces and studied the effects of
these interactions during osteogenic differentiation. DBSCs uniformly
colonized all the three coated surfaces after 2–3 days while in the con-
trol the cells maintained the typical colony-forming unit (CFU) appear-
ance (not shown). This observation is in agreement with other data
demonstrating a strong adhesive interaction between MSCs and RGD-
containing glycoproteins (Schwab et al., 2013; Ode et al., 2010; Klees
et al., 2005; Lavenus et al., 2011; Gronthos et al., 2001). The CFU appear-
ance in the control would suggest a major cell retention in the “niche”
stem status compared to the cells on coated surfaces and thus a less
committed state of the cells. This idea was supported by DBSC expres-
sion of two earlymarkers of osteoblast commitment and differentiation,
Runx-2 and Col I, that were strongly increased in the cells cultured on
VTN and OPN and to a lesser extent on FN. Accordingly, the higher ex-
pression of these genes was accompanied by increased expression of
ALP and enhanced mineral deposition, with no signiﬁcant differenceamong the three glycoproteins. So far these data strengthen the idea
that MSCs from dental tissues could be a good promise for bone tissue
regeneration. Indeed we demonstrated for the ﬁrst time that DBSCs
not only differentiated into osteoblast-like cells depositing mineral ma-
trix (Mori et al., 2012) but also expressed a pattern of adhesion recep-
tors as cadherins very similar to BM-MSCs, switching to the typical
osteoblast phenotype as theyweremaintained in osteogenic conditions.
A main role for cadherins has been established in the control of mesen-
chymal cells survival and osteoblastogenesis, although still remaining a
matter of debate, thus a deeper knowledge of cadherins behavior in
these cells would help to promote their possible use in bone reconstruc-
tion. Furthermore we found that the expression pattern of integrins
would determine the optimal extracellular environment to achieve an
efﬁcacious osteogenic differentiation of these cells. Indeed DBSC differ-
entiation toward osteoblastic lineage was enhanced when cells were
grown on FN, VTN, and OPN. The interaction between αVβ3 and their
ECM partners VTN and OPN appeared to be crucial in DBSC commit-
ment. Indeed the accentuated ALP expression and mineralized matrix
formation obtained growing the cells on VTN and OPN was completely
abolishedwhen cultureswere treatedwithαVβ3 neutralizing antibody.
Fig. 4. Integrin interaction with ECM proteins enhances osteogenic differentiation andmineralization of DBSCs; (A) immunoblots show the expression of two earlymarkers of osteogenic
differentiation, Runx-2 and Collagen I (Col I), in DBSCs seeded and differentiated for 7 days on FN, VTN, OPN coatings and on PLL as control (CTR). Higher levels of both markers are de-
tectable in cells cultured onECMproteins compared to control. One among three representative experimentswas chosen for Image J quantiﬁcation of reactive bands. (B) ALP histochemical
assay (purple staining) performed on DBSCs seeded and differentiated for 7 days on all three surfaces and CTR. Mineralmatrix depositionwas assayed after 21 days by ARS (red staining).
The graphs show quantiﬁcation of positive staining as percentage compared to CTR (*P b 0.001) and are representative for 3 independent donors. Data are presented as mean ± SEM.
Student's t-test was used for single comparisons. (C) ALP staining performed after 7 days and ARS staining after 14 days on DBSCs seeded and differentiated on FN+ α5β1 blocking an-
tibody, VTN+ αVβ3 blocking antibody, OCN+αVβ3 blocking antibody and CTR (*P b 0.001 vs control culture without antibody). Data are representative for 3 independent donors, and
are presented as mean ± SEM. Student's t-test was used for single comparisons.
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inhibition of ALP and ARS staining in cultures performed on FN coating.
Although MSCs adhere to FN via α5β1, it is known that multiple
integrins can bind to a single ECM protein and multiple ECM proteins
can bind a single integrin (Miranti and Brugge, 2002), thus a possible
explanation of these results is that some other integrin couldcompensate for inactivated α5β1 in the binding to FN and give evenly
positive cues to osteogenic differentiation. On the contrary, the results
on αVβ3 inhibition demonstrated that accentuated differentiation
gained on VTN and OPN is mostly exclusively mediated by integrin
αVβ3. Few previous studies reported an involvement of αVβ3 in the
regulation of osteoblastic differentiation, although most of them were
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et al., 2001; Weyts et al., 2002) and some of those demonstrated essen-
tially a synergy with other signaling pathways (Lai and Cheng, 2005;
Kim et al., 2007; Su et al., 2010). However, little is known about the
role of αVβ3 in MSCs commitment to osteoblast lineage. We demon-
strated in DBSCs, which are a good cell model of MSCs, that integrin
αVβ3 is indispensable for the commitment to osteoblast lineage and
its interaction with ECM ligands VTN and OPN enhanced this process.
In conclusion the proﬁle expression of adhesion receptors, and their ex-
pression changing during osteogenic differentiation, reﬂected the mes-
enchymal origin of DBSCs and conﬁrmed their capacity for committing
to osteoblast-like cells. Furthermore these data suggest that stratiﬁca-
tion of biomaterials with ECM protein as FN, VTN, and OPN would im-
prove the bone reconstruction therapies starting from dental stem
cells. In addition we established that Integrin αVβ3 plays a crucial role
during the commitment of MSCs to osteoblast lineage, while Integrin
α5β1 seems to be dispensable.
4. Materials and methods
4.1. Materials
Antibody anti N-Cadherin, E-Cadherin, P-Cadherin, Integrin α5, αV,
β1, and β3 were from BD Bioscience; antibody anti Cadherin-11 was
from Zymed; Antibody anti-αVβ3 clone LM609 and antibody anti-
α5β1 clone JBS5were fromMillipore. Ascorbic acid, β-glicerophosphate,
dexa-methasone, Alizarin red powder and alkaline phosphatase (ALP)
staining kit, poly-L-Lysine, FN, OPN, and VTN were from Sigma Aldrich.
4.2. Patients and dental bud stem cells cultures
Third molar tooth buds were extracted with piezo-surgery from 20
healthy pediatric donors, aged 8–12 years undergoing to extractions
for orthodontics reasons, after obtaining informed consent from each
patients' parents. The study was approved by the Institutional Review
Board of the Department of Clinical and ExperimentalMedicine, Univer-
sity of Foggia and patients' parents gavewritten informed consent. Den-
tal buds (DBs) were dissected, and the peripheral component
corresponding to the enamel organ and to the dental follicle were elim-
inated. The remaining dental papillae were digested for 1 h at 37 °C in
agitation in a solution of 3 mg/ml type I collagenase plus 4 mg/ml
dispase (Gibco Ltd., Uxbridge, UK). Single cell suspensions were obtain-
ed by passing the cells through a 70 μm BD Falcon strainer (Falcon)
(Becton & Dickinson, Sunnyvale, CA, USA). After ﬁltration, single cell
suspensions were centrifuged at 1300 rpm and resuspended in mesen-
chymal stem cell culture medium supplemented with 5% fetal bovine
serum (FBS), 100 U/ml penicillin-G, 100 μg/ml streptomycin (Gibco
Limited, Uxbridge, United Kingdom) at 5 × 103 cells/cm2. Flasks were
incubated at 37 °C and 5% CO2 and the medium was changed every
3 days. For induction of osteogenic differentiation, the cells were seeded
3000/cm2 in α-MEM supplemented with 2% FBS, 10−8 M dexametha-
sone and 50 μg/ml ascorbic acid. To evaluate the ability to form miner-
alized nodules in vitro, 10 mM β-glycerophosphate was added to the
previous medium.
4.3. Immunophenotypic analysis
The followingﬂuorescein isothiocyanate (FITC)-conjugated or phyco-
erythrin (PE)-conjugatedmAbs were used for immunoﬂuorescent stain-
ing of DBSCs: PE-CD73, PE-CD90, sotype control (all BD-Pharmingen,
Milano, Italy), as well as FITC-CD105, and FITC-CD45 (Beckman Coulter,
Inc., Milano, Italy). Cells from each donor were washed in FACS buffer
(phosphate-buffered saline pH 7.2, 0.2% bovine serum albumin, and
0.02% sodiumazide) containing 3%human serum, incubatedwithﬂuoro-
chrome-conjugated mAbs for 30 min and then washed with the same
buffer before ﬂow cytometric analysis. Data were acquired using aMACSQuant® Analyzer 10 (Miltenyi Biotec, Inc., Milan, Italy) ﬂow
cytometer. The area of positivity was determined using an isotype-
matched mAb.4.4. Immunoﬂuorescence
Cells were counted and seeded on glass coverslips, grown in the ap-
propriate culture medium, and then ﬁxed in 4% (PFA)/PBS. The ﬁxed
cells, were washed with PBS, and blocked in 1% BSA, 5% normal goat
serum in PBS for 20 min. The samples were incubated with the follow-
ing antibodies:αV, β3,α5, β1, andαVβ3 (clone LM609 antibody). After
washing, bound antibodieswere detected using 2 μg/ml of ﬂuorescently
labeled goat anti-mouse or anti-rabbit secondary antibody (Alexa Fluor
488, Alexa Fluor 568, Invitrogen); cytoskeleton was counterstained
with Phalloidin (Invitrogen). The cells were then visualized and
photographed using a multispectrum confocal microscope Leica TCS
SP5.4.5. Western blot
The proteins of interest were identiﬁed byWestern blot. The cell ly-
sates were cleared by centrifugation at 13,000 rpm for 15′ at 4 °C. The
supernatant was recovered and the protein concentration was assessed
by protein assay (BIORAD). Equal amounts of proteins for each sample
were separated by SDS-PAGE, transferred to nitrocellulose membranes
(Amersham, UK) using the Trans-Blot (Biorad, USA). The membranes
were incubated overnight at 4 °C with primary antibodies, followed by
the incubation with IRDye-labeled secondary antibodies at room tem-
perature for 90′. The reactionwas displayed by theOdyssey Infrared Im-
aging System of LI-COR (LI-COR Biotechnology Lincoln, Nebraska, USA).4.6. Immunoprecipitation
Cells were lysed and the lysates were cleared by centrifugation at
13,000 rpm for 15′ at 4 °C. The supernatant was recovered and the pro-
tein concentration was assessed by protein assay (BIORAD). The prima-
ry antibodies, LM609 and JBS5, which recognize respectively only the
complex αVβ3 and α5β1 were added to the cell lysates. They were in-
cubated with gentle rocking (put on ice into agitation) for 2 h at 4 °C.
Protein G was added and incubated with a gentle rocking at 4 °C over-
night. The next day the samples were centrifuged, washed, and ﬁnally
western blotted with αV and β3 antibodies, α5 and β1 antibodies.4.7. ECM glycoproteins and coating procedure
Tissue culture treated polystyrene surfaces were coated with
vitronectin (VN, human plasma, 0.5 μg/cm2, Sigma, Steinheim, Germa-
ny), ﬁbronectin (FN, human plasma, 4 μg/cm2, Sigma) and osteopontin
(OPN, human recombinant, 0.5 μg/cm2, Sigma) diluted in 1 × phosphate
buffered saline (PBS, pH 7.2, PAA, Coelbe, Germany) or water according
to the manufacturers' recommendations. Poly-L-lysine (PLL, 2 μg/cm2,
Sigma) was used as control. The different amounts ensured the com-
plete coating of the surface for each type of ECM protein. Surface were
coated with the ECM protein solution for 30 min at 37 °C, washed
twice with PBS, blocked with 1% bovine serum albumin (BSA, Sigma)
in PBS for 10 min at room temperature and sterilized with UV light for
30 min. To conﬁrm the coating adsorption, the protein content in the
coating solution was measured using a micro BCA assay. The amount
of adsorbed protein was determined by calculating the difference in
the coating solutions pre- and post-coating. Additionally, the coatings
were validated by ﬂuorescence microscopy using ﬂuorescently labeled
proteins (data not shown).
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The expression of ALP, a biochemical marker for the osteoblastic ac-
tivity, was assessed inDBSCs, grown in osteogenicmedium,with a com-
mercial kit: Leukocyte Alkaline Phosphatase Kit (Sigma Aldrich). Cells
were ﬁxed with a ﬁxative solution provided from the kit for 30″ at
room temperature. After being gently rinsed with distilled water, cells
were stained in the dark with ALP solution (a mixture of FRV-Alkaline
Solution, Naphthol AS-BI Alkaline Solution, NaNO2) for 15′, washed
with water, air dried and then analyzed under the microscope. Osteo-
blasts positive for ALP show a purple color.
4.9. Alizarin red staining (ARS)
ARS is a method to detect calcium-rich deposits in cell cultures. The
cell culture medium was removed before the staining procedure, the
cells were rinsed gently with the same volume or more of PBS and
ﬁxed by adding 0.5 ml of 10% formalin per well at room temperature
for 10 min. Fixative residues were removed by washing twice with de-
ionized water, with the same volume used to ﬁx. 1% ARS solution was
added, 0.5 ml per well, and incubated at room temperature for
10 min. ARS solution was discarded, the wells were rinsed twice with
deionized water and air dried. The monolayer appeared red stained.
4.10. Statistical analyses
Statistical analyses were performed by Student's t-test with the Sta-
tistical Package for the Social Sciences (spssx/pc) software (SPSS, Chica-
go, IL, USA). The results were considered statistically signiﬁcant for
p b 0.05.
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